Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Dysregulation as the Underlying Principle of Integrated Pathophysiology of Obesity-associated Chronic Diseases: Molecular Landscape of Complex Lifestyle Modification

NCT06954298 is registered in ClinicalTrials.gov with Slovak Academy of Sciences as lead sponsor.

NCT NCT06954298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06954298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Dysregulation as the Underlying Principle of Integrated Pathophysiology of Obesity-associated Chronic Diseases: Molecular Landscape of Complex Lifestyle Modification
Lead sponsor
Slovak Academy of Sciences
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 15, 2024
Completion date
June 30, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic disease, obesity, obesity prevention